These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4565653)

  • 41. STUDIES ON THE ROLE OF THE THYMUS IN IMMUNOBIOLOGY; RECONSTITUTION OF IMMUNOLOGIC CAPACITY IN MICE THYMECTOMIZED AT BIRTH.
    DALMASSO AP; MARTINEZ C; SJODIN K; GOOD RA
    J Exp Med; 1963 Dec; 118(6):1089-109. PubMed ID: 14112268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alloantibodies in relation to the rejection of skin allografts in the mouse.
    Harris TN; Harris S
    Adv Exp Med Biol; 1976; 73 Pt B():253-67. PubMed ID: 793335
    [No Abstract]   [Full Text] [Related]  

  • 43. Various effects of alloantibody-containing globulins on the time of retention of skin allografts in the mouse.
    Harris TN; Harris S; Bocchieri MH; Farber MB; Ogburn CA
    Transplantation; 1972 Oct; 14(4):495-500. PubMed ID: 4566165
    [No Abstract]   [Full Text] [Related]  

  • 44. Bone marrow-derived T lymphocytes responsible for allograft rejection.
    Senjanović M; Marusić M
    Cell Immunol; 1984 Aug; 87(1):225-30. PubMed ID: 6204774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the capacity of neonatal skin grafts to induce tolerance in adult mice.
    Wachtel SS; Silvers WK
    Adv Biol Skin; 1971; 11():223-31. PubMed ID: 4950053
    [No Abstract]   [Full Text] [Related]  

  • 47. Autologous lymphoid cells exposed to recombinant interleukin-2 in vitro in the absence of antigen can induce the rejection of long-term tolerated skin allografts.
    Loveland B; Hunt R; Malkovský M
    Immunology; 1986 Sep; 59(1):159-61. PubMed ID: 3530983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy.
    Koshiba T; Van Damme B; Lu Y; Yan Y; Rutgeerts O; Overbergh L; Tanaka K; Waer M; Mathieu C; Pirenne J
    Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J; Kaden K
    Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
    [No Abstract]   [Full Text] [Related]  

  • 50. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.
    Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH
    J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of calf thymus extracts (TFX) and their glycopeptide fractions on skin allotransplant survival time in mice].
    Turowski G; Kołodziej J
    Pol Przegl Chir; 1980 Sep; 52(9):773-80. PubMed ID: 7003565
    [No Abstract]   [Full Text] [Related]  

  • 52. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partial specific unresponsiveness to second-set allografts following chronic rejection of first-set allografts.
    Végh P; Jánossy T; Erdös E; Petri G; Kováta TG
    Transplantation; 1976 Sep; 22(3):303-5. PubMed ID: 788255
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolongation of skin graft survival in mice by 6-mercaptopurine riboside.
    Ogata M; Yanagimoto S
    Tohoku J Exp Med; 1974 Feb; 112(2):129-31. PubMed ID: 4599226
    [No Abstract]   [Full Text] [Related]  

  • 55. The "Sk" (skin-specific) rejection phenomenon as evidence of the natural role of acquired tolerance.
    Steinmuller D; Lofgreen JS
    Transplant Proc; 1977 Jun; 9(2):1385-91. PubMed ID: 327636
    [No Abstract]   [Full Text] [Related]  

  • 56. Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection.
    Loveland BE; McKenzie IF
    Transplantation; 1982 Apr; 33(4):407-10. PubMed ID: 7041367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunodepressive action of anthracycline antibiotics studied on 2 different transplantation immunity models].
    Liashenko VA; Shapovalova SP; Aleksander SK
    Antibiotiki; 1981 Jul; 26(7):546-9. PubMed ID: 7023378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the H-2 gene dose on the rejection of skin grafts.
    McKenzie IF
    Transplantation; 1973 Jun; 15(6):555-63. PubMed ID: 4123701
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of polyunsaturated fatty acids on skin allograft survival and primary and secondary cytotoxic response in mice.
    Mertin J
    Transplantation; 1976 Jan; 21(1):1-4. PubMed ID: 1108321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.